Armada Health Care streamlines prior auth with free ApproveRx service
Getting prior authorization for reimbursement for specialty pharmaceuticals can be a key stumbling block to connecting patients with prescribed meds. Without the prior auth, patients sometimes return to their physician to seek cheaper or alternative meds that their health plans allow. Now, Armada Health Care (Florham Park, NJ) has collected the prior authorization forms of “virtually all insurance plans and drugs,” according to the company, and makes them available, free, at the ApproveRx website. Prescribers can download the forms, pre-populate them with existing patient data, and get the forms on their way to the health plan. A dashboard feature allows for tracking the authorization status, which Armada says will reduce the incidence of abandoned prescriptions.
“This is an adaption of our existing ReachRx Online Therapy Management service for Armada pharmacy members,” says Darcy Brennan, VP of marketing at Armada. ReachRx OTM automates pharmacy care and intervention scheduling for pharmacists, thereby enhancing the service offering of Armada to those pharmacies. Brennan says that a natural next step for ApproveRx will be to automate the prior auth process through to health plan decisions—but that would require a much higher degree of IT linkage with plans than is available now.
Coincidentally, Armada has now set the agenda for its annual Health Care Summit (May 1-4, Las Vegas), which it expects will draw 2,000 participants from the specialty pharmacy (and pharmaceutical) industry. Philip Hagerman, CEO of Diplomat Pharmacy, will keynote.
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.
New UK Consortium Obtains $1.34M Grant to Launch Automated Cell Therapy Manufacturing Platform
July 15th 2025Cellular Origins, CGT Catapult, and Resolution Therapeutics partner up to design a fully automated, scalable CGT manufacturing solution, with the goal of accelerating patient access to cell therapies.
Study Connects COVID-19 Treatment Disparities to Gaps in Testing and Virtual Access
July 11th 2025New research finds that nearly half of the racial and ethnic disparities in outpatient COVID-19 antiviral prescriptions stem from encounter-level care barriers, such as limited access to rapid tests and telehealth, which emphasizes the need for systemic and practice-level reforms.
New UK Consortium Obtains $1.34M Grant to Launch Automated Cell Therapy Manufacturing Platform
July 15th 2025Cellular Origins, CGT Catapult, and Resolution Therapeutics partner up to design a fully automated, scalable CGT manufacturing solution, with the goal of accelerating patient access to cell therapies.
Study Connects COVID-19 Treatment Disparities to Gaps in Testing and Virtual Access
July 11th 2025New research finds that nearly half of the racial and ethnic disparities in outpatient COVID-19 antiviral prescriptions stem from encounter-level care barriers, such as limited access to rapid tests and telehealth, which emphasizes the need for systemic and practice-level reforms.
485 Route 1 South,
Building F, Suite 210
Iselin, NJ 08830